Praxis Precision Medicines, Inc. PRAX Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Praxis Precision Medicines, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Praxis Precision Medicines, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Praxis Precision Medicines, Inc.'s operating lease ROU assets?
- Praxis Precision Medicines, Inc. (PRAX) reported operating lease ROU assets of $1.32M in Q1 2026.
- How has Praxis Precision Medicines, Inc.'s operating lease ROU assets changed year-over-year?
- Praxis Precision Medicines, Inc.'s operating lease ROU assets increased by 49.7% year-over-year, from $882K to $1.32M.
- What is the long-term trend for Praxis Precision Medicines, Inc.'s operating lease ROU assets?
- Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s operating lease ROU assets has grown at a -34.3% compound annual growth rate (CAGR), from $754K to $92K.
- What does operating lease ROU assets mean?
- This asset represents the company's right to use a leased item, such as office space or data center facilities, over the lease term. It is recognized under modern accounting standards to reflect the financial commitment of long-term operating leases. It provides visibility into the company's fixed operational footprint.